Physician profile
Nathan Peterson
NPI 1053459867
$1,345.48
in general payments reported to CMS, 2019-2025
15 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $123 · 2021: $194 · 2022: $156 · 2023: $160 · 2024: $218 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.70 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $696.46 | 2019-2025 | |
| Amgen INC. | $103.90 | 2019-2024 | Otezla |
| Regeneron Healthcare Solutions, INC. | $97.78 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $94.99 | 2025 | Tremfya |
| Ucb, INC. | $56.58 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $56.24 | 2024 | Zoryve |
| Dermavant Sciences, INC. | $56.02 | 2022-2024 | Vtama |
| Genzyme Corporation | $44.48 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.14 | 2023 | Spevigo, Cyltezo |
| Leo Pharma INC. | $23.17 | 2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $20.22 | 2021 | |
| Organon LLC | $18.47 | 2025 | Vtama |
| Merck Sharp & Dohme LLC | $17.26 | 2019 | |
| Celgene Corporation | $16.76 | 2019 | |
| Lilly USA, LLC | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.